CWA Asset Management Group LLC Makes New Investment in Core Laboratories Inc. $CLB

CWA Asset Management Group LLC bought a new stake in Core Laboratories Inc. (NYSE:CLB) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 622,453 shares of the oil and gas company’s stock, valued at approximately $9,978,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in the company. Quarry LP lifted its stake in shares of Core Laboratories by 118.1% during the third quarter. Quarry LP now owns 2,953 shares of the oil and gas company’s stock valued at $36,000 after acquiring an additional 1,599 shares during the period. GAMMA Investing LLC boosted its holdings in Core Laboratories by 73.3% in the fourth quarter. GAMMA Investing LLC now owns 5,157 shares of the oil and gas company’s stock valued at $83,000 after acquiring an additional 2,181 shares during the last quarter. Tower Research Capital LLC TRC increased its position in Core Laboratories by 400.9% in the second quarter. Tower Research Capital LLC TRC now owns 7,333 shares of the oil and gas company’s stock worth $84,000 after purchasing an additional 5,869 shares during the period. Vestcor Inc acquired a new stake in Core Laboratories in the third quarter worth about $101,000. Finally, Mercer Global Advisors Inc. ADV bought a new stake in Core Laboratories during the 3rd quarter worth about $132,000. Institutional investors own 97.81% of the company’s stock.

Core Laboratories Stock Up 1.3%

Core Laboratories stock opened at $16.18 on Friday. The firm has a market capitalization of $753.15 million, a price-to-earnings ratio of 24.14, a PEG ratio of 13.93 and a beta of 1.10. The company’s 50 day simple moving average is $18.08 and its 200 day simple moving average is $15.79. The company has a debt-to-equity ratio of 0.39, a current ratio of 2.07 and a quick ratio of 1.57. Core Laboratories Inc. has a fifty-two week low of $9.72 and a fifty-two week high of $20.36.

Core Laboratories (NYSE:CLB) last issued its earnings results on Wednesday, February 4th. The oil and gas company reported $0.21 EPS for the quarter, beating the consensus estimate of $0.20 by $0.01. The firm had revenue of $138.26 million during the quarter, compared to the consensus estimate of $130.40 million. Core Laboratories had a net margin of 6.04% and a return on equity of 12.09%. The business’s quarterly revenue was up 7.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.22 earnings per share. Core Laboratories has set its Q1 2026 guidance at 0.110-0.150 EPS. As a group, sell-side analysts anticipate that Core Laboratories Inc. will post 0.96 EPS for the current year.

Core Laboratories Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, March 9th. Investors of record on Monday, February 16th were given a $0.01 dividend. The ex-dividend date was Friday, February 13th. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.2%. Core Laboratories’s dividend payout ratio is currently 5.97%.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a “hold (c)” rating on shares of Core Laboratories in a research report on Monday, December 29th. Four equities research analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, Core Laboratories presently has a consensus rating of “Hold” and a consensus price target of $12.50.

Core Laboratories Company Profile

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.